Life sciences software & AI news

Daily news on AI, software, and digital tools for pharma, biotech, CROs, and life sciences research labs.

Showing 1000+ results
Molecular model on a lab table with a research notebook

May 28, 2026

Hoffman Predicts AI-Driven Drug Discovery Bonanza

Reid Hoffman, co-founder of LinkedIn and Manas AI, recently highlighted the transformative potential of AI in drug discovery during an appearance on "The Possible Podcast." He emphasized that the market for AI-driven drug discovery could surpass that of current AI chatbot applications.Hoffman pointed out that the existing chatbot market, dominated by companies like OpenAI and Anthropic, is significant, but the opportunities in drug discovery are even greater. He noted that AI technologies can si
A syringe on a medical chart in a dimly lit examination room

May 28, 2026

OptimizeRx vs. Doximity: Which Digital Health Stock Is the Better Bet?

OptimizeRx and Doximity are both key players in the digital health sector, leveraging technology to enhance communication and workflow efficiency in healthcare. However, they face a challenging advertising landscape that impacts their growth potential.OptimizeRx is experiencing significant growth, particularly with its AI-driven DAAP solution, which saw a 60% increase in the first quarter. The company has successfully expanded its client base among major pharmaceutical firms, transitioning from
A minimalist representation of a drug capsule and heart symbol in a dark palette.

May 28, 2026

AI-Designed Drug Enters Phase I Trial

Quotient Sciences has launched a Phase I clinical trial for a novel drug product, developed using artificial intelligence (AI), marking a potential breakthrough in AI-driven drug formulation.The trial, conducted at Quotient Sciences' UK facility, has received approval from the MHRA and aims to assess the safety and pharmacokinetics of the drug in healthy volunteers. This initiative is significant as it seeks to validate AI's role in drug development, potentially enhancing formulation design and
A minimalist illustration of a pill and tablet on a dark background.

May 28, 2026

Solstice Secures $21M Series A for Pharma Innovation

Solstice, a New York-based AI marketing platform tailored for the pharmaceutical sector, has successfully raised $21 million in Series A funding to enhance its innovative solutions aimed at expediting the drug commercialization process.The company’s AI engine significantly reduces the traditionally lengthy medical, legal, and regulatory (MLR) review process, condensing approval timelines from several months to as little as 10 days. This transformation is critical, as the MLR review often delays
A minimalist illustration of a pill bottle representing non-opioid pain therapy.

May 28, 2026

Redwood AI Bridges Markets and Medicine with DTC Eligibility and Pharma Partnership

Redwood AI is making significant strides in the life sciences sector by securing DTC eligibility for US trading and partnering with Resilience Biosciences to develop non-opioid pain therapies.This week, Redwood AI has advanced its dual growth strategy, marking its entry into life sciences through a collaboration with Resilience Biosciences. The partnership aims to tackle the pressing issue of finding alternatives to opioid pain management. Utilizing its advanced computational chemistry platform,
A non-opioid therapeutic compound in a laboratory setting

May 28, 2026

Redwood AI Moves on Two Fronts: US Trading Clearance and Pharma Partnership to Drive Commercial Mome

Redwood AI is making significant strides in both market accessibility and pharmaceutical collaboration, aiming to enhance its commercial potential.The company has recently achieved DTC eligibility for its shares, facilitating easier trading for US investors. This move is designed to improve liquidity and trading efficiency, addressing previous challenges associated with manual processes in the OTCQB market. Alongside this, Redwood AI has formed a partnership with Resilience Biosciences to develo
A minimalist representation of automation in life sciences.

May 28, 2026

ISG Provider Lens Study Features Marlabs for Life Sciences Digital Services 2026

Marlabs has been recognized in the ISG Provider Lens® Life Sciences Digital Services 2026 Global Study, highlighting its capabilities in two key areas: Manufacturing and Supply Chain, and Pharmacovigilance and Regulatory Affairs.The ISG report evaluates IT service providers and Contract Research Organizations (CROs) on their ability to facilitate digital transformation in the life sciences sector. Marlabs stands out for its expertise in leveraging AI, data, and automation to help life sciences c
A minimalist workflow diagram in a dark palette with lime accents.

May 28, 2026

Causaly Introduces Scientific Workflows to Turn Expert Scientific Methods into Repeatable, AI-Executed Processes in Life Sciences

Causaly has launched Scientific Workflows, a new feature in its AI platform aimed at transforming expert scientific methods into standardized, autonomous workflows for life sciences organizations.This innovative solution allows biopharma R&D teams to codify their research processes into structured workflows that AI can execute consistently. By doing so, it produces reliable outputs such as target assessments and safety dossiers, enabling teams to scale their research methodologies and enhance de
A tissue sample on a microscope slide in a lab setting

May 28, 2026

Finnish researchers use AI to accelerate colorectal cancer diagnostics

Researchers at the University of Jyväskylä have developed an artificial intelligence model that significantly enhances the speed and accuracy of colorectal cancer diagnostics by analyzing tissue samples and predicting DNA repair mechanisms.This innovative approach addresses the traditionally time-consuming process of evaluating cancer samples, which can take several days in pathology laboratories. The AI model can reduce this analysis time to mere minutes, potentially leading to significant cost
A minimalist representation of DNA and AI integration in biotech

May 28, 2026

Small Biotech Firms Embrace AI Faster Than Industry Giants, Tencent Healthcare President Says

Smaller biotech firms are outpacing larger pharmaceutical companies in the adoption of artificial intelligence, according to Alex Ng, President of Tencent Healthcare. This trend highlights a significant shift in the industry as companies increasingly leverage AI to enhance efficiency and cut operational costs.Ng's comments come as the pharmaceutical sector is actively exploring AI to accelerate research and development processes. By utilizing advanced modeling tools and automated laboratories, f
A pill bottle on a desk with marketing materials in a dimly lit office.

May 28, 2026

AI-native pharma marketing startup Solstice raises $21M to cut drug campaign timelines from 3 months to 10 days

AI-driven startup Solstice has successfully raised $21 million in Series A funding to revolutionize pharmaceutical marketing timelines, reducing the approval process from months to mere days.Based in New York, Solstice aims to streamline the traditionally cumbersome marketing and regulatory review processes in the pharmaceutical industry. With over a dozen pharmaceutical partners, including major global brands, the startup leverages AI to cut the time from content creation to regulatory submissi
A minimalist illustration of a brain and an MRI machine on a dark background.

May 28, 2026

Simulations + AI = faster brain MRI scans

Recent advancements in MRI technology are poised to significantly enhance brain imaging efficiency and accuracy. Researchers at the Institute for Neurosciences CSIC-UMH have developed a method that combines simulations with artificial intelligence to reduce the time needed for MRI scans, enabling the integration of more sophisticated imaging techniques.This innovative approach not only accelerates scan times but also mitigates biases typically found in traditional clinical datasets. By leveragin